# A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Study · id `cardio:ct-nct05295290` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05295290](<https://clinicaltrials.gov/study/NCT05295290>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05295290

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 319 participants.

## Technical summary

Registry record NCT05295290. Non-randomized; no masking; primary purpose other. Start 2022-11-21 (actual); primary completion 2029-04-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 319 participants (enrolled count; ClinicalTrials.gov record NCT05295290, source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)
- Started: 2022-11-21 (actual) (ClinicalTrials.gov record NCT05295290, source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)
- Primary completion: 2029-04-02 (anticipated) (ClinicalTrials.gov record NCT05295290, source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)
- Completion: 2029-04-02 (anticipated) (ClinicalTrials.gov record NCT05295290, source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05295290, source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05295290-2026-05-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
- Condition: Myocarditis
- Intervention (Diagnostic test): Cardiac Imaging
- Lead sponsor: Pfizer
- Lead sponsor class: INDUSTRY
- Collaborator: Carelon Research
- Collaborator class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry lists this organization as the lead sponsor: Pfizer (`cardio:org-pfizer`)
- Registry lists this organization as a collaborator: Carelon Research (`cardio:org-carelon-research`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: fb4a2518cd7d01ef35cb20aa3068fcf15011c6bd17db5cc8086dad6633896286
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
